Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE (Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination) trial

PURPOSE: To report the clinical efficacy of sorafenib and to evaluate biomarkers associated with sorafenib clinical benefit in the BATTLE program. PATIENTS AND METHODS: Patients with previously treated non-small–cell lung cancer (NSCLC) received sorafenib until progression or unacceptable toxicity....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Blumenschein, George R., Saintigny, Pierre, Liu, Suyu, Kim, Edward S., Tsao, Anne S., Herbst, Roy S., Alden, Christine, Lee, J. Jack, Tang, Ximing, Stewart, David J., Kies, Merrill S., Fossella, Frank V., Tran, Hai T., Mao, L., Hicks, Marshall E., Erasmus, Jeremy, Gupta, Sanjay, Girard, Luc, Peyton, Michael, Diao, Lixia, Wang, Jing, Davis, Suzanne E., Minna, John, Wistuba, Ignacio, Hong, Waun K., Heymach, John V., Lippman, Scott M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3905243/
https://ncbi.nlm.nih.gov/pubmed/24166906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-1818
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados